Journal article
Hereditary neuropathy
Handbook of clinical neurology, Vol.195, pp.609-617
2023
DOI: 10.1016/B978-0-323-98818-6.00009-1
PMID: 37562889
Abstract
The hereditary neuropathies, collectively referred as Charcot-Marie-Tooth disease (CMT) and related disorders, are heterogeneous genetic peripheral nerve disorders that collectively comprise the commonest inherited neurological disease with an estimated prevalence of 1:2500 individuals. The field of hereditary neuropathies has made significant progress in recent years with respect to both gene discovery and treatment as a result of next-generation sequencing (NGS) approach. These investigations which have identified over 100 causative genes and new mutations have made the classification of CMT even more challenging. Despite so many different mutated genes, the majority of CMT forms share a similar clinical phenotype, and due to this phenotypic homogeneity, genetic testing in CMT is increasingly being performed through the use of NGS panels. The majority of patients still have a mutation in one the four most common genes (PMP22 duplication-CMT1A, MPZ-CMT1B, GJB1-CMTX1, and MFN2-CMT2A). This chapter focuses primarily on these four forms and their potential therapeutic approaches.
Details
- Title: Subtitle
- Hereditary neuropathy
- Creators
- Chiara Pisciotta - Fondazione IRCCS Istituto Neurologico Carlo BestaMichael E Shy - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Handbook of clinical neurology, Vol.195, pp.609-617
- Publisher
- Elsevier
- DOI
- 10.1016/B978-0-323-98818-6.00009-1
- PMID
- 37562889
- ISSN
- 0072-9752
- eISSN
- 2212-4152
- Language
- English
- Date published
- 2023
- Academic Unit
- Neurology; Molecular Physiology and Biophysics; Iowa Neuroscience Institute
- Record Identifier
- 9984455492602771
Metrics
10 Record Views